INFINITY PHARMACEUTICALS

Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, in multiple clinical studies. MARIO-275 is a global, randomized, placebo-controlled study of eganelisib combined with Opdivo® in I/O naïve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is... evaluating eganelisib in combination with Tecentriq® and Abraxane® in front-line TNBC and in combination with Tecentriq and Avastin® in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (dual adenosine receptor antagonist) plus Doxil® in advanced TNBC patients. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I/O-naïve, and front-line and second line settings.

#SimilarOrganizations #People #Financial #Event #Website #More

INFINITY PHARMACEUTICALS

Social Links:

Twitter

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2001-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.infi.com

Total Employee:

51+

Status:

Active

Contact:

617-453-1000

Email Addresses:

[email protected]

Total Funding:

538.04 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache

Similar Organizations

ablynx-logo

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.

aeovian-pharmaceuticals-logo

Aeovian Pharmaceuticals

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

biorelix-logo

BioRelix

BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

idenix-pharmaceuticals-logo

Idenix Pharmaceuticals

Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

merrimack-pharmaceuticals-logo

Merrimack Pharmaceuticals

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

navitor-pharmaceuticals-logo

Navitor Pharmaceuticals

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

neurocrine-biosciences-logo

Neurocrine Biosciences

Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

uluru-logo

ULURU

ULURU engages in the research, development, and commercialization of wound care and mucoadhesive film products.

Current Advisors List

anthony-evnin_image

Anthony Evnin Board Member @ Infinity Pharmaceuticals
Board_member

michael-venuti_image

Michael Venuti Member of Board @ Infinity Pharmaceuticals
Board_member

norman-selby_image

Norman Selby Member of Board @ Infinity Pharmaceuticals
Board_member

adelene-perkins_image

Adelene Perkins Member of Board of Directors @ Infinity Pharmaceuticals
Board_member

brian-schwartz_image

Brian Schwartz Board of Directors @ Infinity Pharmaceuticals
Board_member
2021-09-01

Current Employees Featured

lawrence-bloch_image

Lawrence Bloch
Lawrence Bloch President @ Infinity Pharmaceuticals
President

jennifer-roberts_image

Jennifer Roberts
Jennifer Roberts VP, Clinical Development Operations @ Infinity Pharmaceuticals
VP, Clinical Development Operations
2019-09-01

rossitza-alargova_image

Rossitza Alargova
Rossitza Alargova Head of Pharmaceutical Development @ Infinity Pharmaceuticals
Head of Pharmaceutical Development
2019-04-01

robert-ilaria_image

Robert Ilaria
Robert Ilaria Chief Medical Officer @ Infinity Pharmaceuticals
Chief Medical Officer
2021-09-01

adelene-perkins_image

Adelene Perkins
Adelene Perkins Chair and Chief Executive Officer @ Infinity Pharmaceuticals
Chair and Chief Executive Officer
2012-01-01

karen-mcnamara_image

Karen McNamara
Karen McNamara Senior Director, Product Development & Supply Operations @ Infinity Pharmaceuticals
Senior Director, Product Development & Supply Operations

seth-tasker_image